|
Biotech Showcase January 8-10, 2018
|
1
|
BIOASIS TECHNOLOGIES INC
|
Dec 15, 2017 11:56AM
|
|
Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction
|
1
|
Resverlogix Corp.
|
Aug 28, 2017 08:19AM
|
|
Re: RRR %
|
1
|
Resverlogix Corp.
|
Jul 01, 2019 12:45PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
1
|
Resverlogix Corp.
|
Dec 03, 2021 10:36AM
|
|
Re: Priceless on I.V. Regarding Zenith
|
1
|
Zenith Epigenetics
|
Apr 07, 2017 12:32PM
|
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
1
|
Resverlogix Corp.
|
Oct 31, 2016 11:32AM
|
|
Re: Must be a dilutive financing in the works...
|
1
|
Resverlogix Corp.
|
Oct 18, 2018 11:32AM
|
|
biOasis to Present at BIO International in San Francisco on June 7, 2016
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 18, 2016 10:35AM
|
|
Re: Bioasis Announces Publication of Independent Research by MedImmune Validating xB3 Platform Technology
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 30, 2018 08:51AM
|
|
Re: Resverlogix and Zenith AGMs
|
1
|
Resverlogix Corp.
|
Aug 23, 2016 09:36AM
|
|
Re: Timing of BETonMACE data
|
1
|
Resverlogix Corp.
|
Jun 10, 2019 02:19PM
|
|
Re: Full presentation:
|
1
|
Resverlogix Corp.
|
Nov 16, 2019 01:07PM
|
|
Re: No Threats?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 01, 2016 01:50PM
|
|
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
|
1
|
Zenith Epigenetics
|
Feb 05, 2019 05:28PM
|
|
Executive Video Twitter Post/Link to RVX video from January
|
1
|
Resverlogix Corp.
|
Jul 20, 2015 10:41PM
|
|
Re: RRR %
|
1
|
Resverlogix Corp.
|
Jul 01, 2019 02:05PM
|
|
Re: #Covid19 Interview of Nevan Krogan, PDF of article
|
1
|
Resverlogix Corp.
|
Mar 27, 2020 12:54PM
|
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
1
|
Resverlogix Corp.
|
Oct 31, 2016 11:47AM
|
|
Next up.....
|
1
|
Resverlogix Corp.
|
May 02, 2018 05:28PM
|
|
Re: Financial Future
|
1
|
Resverlogix Corp.
|
May 14, 2019 09:22AM
|
